Frederique J. Vink

Methylation markers <scp><i>FAM19A4</i></scp> and <i><scp>miR124</scp>‐2</i> as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Jesper Bonde, Arno Floore, Ditte Møller Ejegod et al. · International Journal of Cancer · 2020 · 113 citations · Full text

<i>FAM19A4/miR124‐2</i> methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

Frederique J. Vink, Chris J.L.M. Meijer, Gary M. Clifford et al. · International Journal of Cancer · 2019 · 72 citations · Full text

FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort

Frederique J. Vink, Birgit I. Lissenberg‐Witte, Chris J.L.M. Meijer et al. · Clinical Microbiology and Infection · 2020 · 52 citations · Full text

Hpv-positive Women, Cervical Health, Fam19a4/mir124-2 Methylation Analysis +12

Classification of high‐grade cervical intraepithelial neoplasia by p16^ink4a, Ki‐67, <scp>HPV E4</scp> and <i><scp>FAM19A4</scp>/<scp>miR124</scp>‐2</i> methylation status demonstrates considerable heterogeneity with potential consequences for management

Frederique J. Vink, Stèfanie Dick, Daniëlle A.M. Heideman et al. · International Journal of Cancer · 2021 · 50 citations · Full text

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping

Stèfanie Dick, Frederique J. Vink, Daniëlle A.M. Heideman et al. · British Journal of Cancer · 2021 · 38 citations · Full text